Does Replacement With CMVIG in Hypogammaglobulinemic Patients Decrease the Rate of Opportunistic Infections and Chronic Rejection?
Published in ClinicalTrials.gov • Jan 1, 2001
Authors:
MD Jeff T Chapman
Abstract
This is a randomized controlled trial of CMV-Ig in lung transplant recipients at the Cleveland Clinic Foundation who are hypogammaglobulinemic.
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!